Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13480342 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL31299139 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL31299234 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL31299153 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL9253777 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL5570788 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL5574602 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL31299121 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL4534251 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 | |
| SCHEMBL27588886 | 1.00 | TSHR (0.40) | TSHRTHRBLMNADNM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12331164-B2 | Curable siloxane resin composition | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-06-17 | — | — | US | claimed |
| CN-118698489-A | Adsorbents, devices, kits and methods useful for biological sample processing | 沃特世科技公司 | 2024-09-27 | — | — | CN | claimed |
| EP-4354134-A2 | SORBENTS, DEVICES, KITS AND METHODS USEFUL FOR BIOLOGICAL SAMPLE TREATMENT | Waters Technologies Corporation (US) | 2024-04-17 | — | — | EP | claimed |
| US-20230078587-A1 | CURABLE SILOXANE RESIN COMPOSITION | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-03-16 | — | — | US | claimed |
| US-20220280909-A1 | SORBENT PARTICLES FOR SAMPLE TREATMENT | WATERS TECHNOLOGIES CORPORATION (US) | 2022-09-08 | — | — | US | claimed |
| US-11376561-B2 | Sorbent particles for sample treatment | WATERS TECHNOLOGIES CORPORATION (US) | 2022-07-05 | — | — | US | claimed |
| EP-3860755-A1 | SORBENTS, DEVICES, KITS AND METHODS USEFUL FOR BIOLOGICAL SAMPLE TREATMENT | Waters Technologies Corporation (US) | 2021-08-11 | — | — | EP | claimed |
| CN-113164910-A | Adsorbents, devices, kits and methods useful for biological sample processing | 沃特世科技公司 | 2021-07-23 | — | — | CN | claimed |
| WO-2020072668-A1 | SORBENTS, DEVICES, KITS AND METHODS USEFUL FOR BIOLOGICAL SAMPLE TREATMENT | WATERS TECHNOLOGIES CORPORATION (US) | 2020-04-09 | — | — | WO | claimed |
| US-20200101437-A1 | SORBENTS, DEVICES, KITS AND METHODS USEFUL FOR SAMPLE TREATMENT | WATERS TECHNOLOGIES CORPORATION | 2020-04-02 | — | — | US | claimed |
| US-6555678-B1 | Reacting with a silylating agent, extracting the silylated cellulose from the synthesis reaction medium, spinning through extrusion die(s), and treating the resultant yarn with a desilylation agent to regenerate the celluose and a siloxane | RHODIA ACETOW (DE) | 2003-04-29 | — | — | US | claimed |
| EP-1025291-B1 | METHOD FOR PREPARING A REGENERATED CELLULOSE FIBRE OR YARN | RHODIA ACETOW (DE) | 2003-04-09 | — | — | EP | claimed |
| US-12559632-B2 | Weather-resistant, fungal-resistant, and stain-resistant coatings and methods of applying on wood, masonry, or other porous materials | UNIVERSITY OF HOUSTON SYSTEM (US) | 2026-02-24 | — | — | US | disclosed |
| US-12331164-B2 | Curable siloxane resin composition | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-06-17 | — | — | US | disclosed |
| US-12312534-B2 | Treating fluid comprising hydrocarbons, water, and polymer | CHEVRON U.S.A. INC. (US) | 2025-05-27 | — | — | US | disclosed |
| US-12215276-B2 | Ph control in fluid treatment | CHEVRON U.S.A. INC. (US) | 2025-02-04 | — | — | US | disclosed |
| US-20020147293-A1 | Porous hybrid particles with organic groups removed from the surface | WATERS TECHNOLOGIES CORPORATION | 2002-10-10 | — | — | US | disclosed |
| WO-2002060562-A1 | POROUS HYBRID PARTICLES WITH ORGANIC GROUPS REMOVED FROM THE SURFACE | WATERS INVESTMENTS LIMITED (US) | 2002-08-08 | — | — | WO | disclosed |
| US-6111126-A | Method for synthesizing organosilicon compounds that contain a functional group bonded to silicon across the Si-C bond | DOW CORNING ASIA, LTD. (JP) | 2000-08-29 | — | — | US | disclosed |
| EP-1006118-A2 | Method for synthesizing organosilicon compounds that contain a group bonded to silicon across the SI-C bond | Dow Corning Asia, Ltd. (JP) | 2000-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559632-B2 | Weather-resistant, fungal-resistant, and stain-resistant coatings and methods of applying on wood, masonry, or other porous materials | GMDS, MGAM, STS | TSHR 2419/4885THRB 2832/4885LMNA 1177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.